Loading...

BBLG BONE BIOLOGICS CORP Delisting Actions 8-K Filing

BN B

BBLG

BONE BIOLOGICS CORP

(BBLG)

2023 8-K

Show Summary

Summary

Equity Offerings

Reverse Stock Split

Reverse Stock Split

Annual Meeting Notice

Share Offering Update

Board Appointment

Director Resignation

Annual Meeting Results

Entry into Material Definit...

Amendment to CEO and CFO Le...

Public Offering

Progress with NB1 clinical ...

Settlement Agreement

Appointment of Director

Compliance regained

Resignation of Director

Reverse Stock Split

Special Meeting and Nasdaq ...

Securities Purchase Agreement

Amendment to Bylaws

Management Changes

Agreement for Public Offering

Reverse Stock Split

External Links:

Bone Biologics Corp received a notice from Nasdaq stating that it no longer satisfies the $1.00 bid price requirement and its securities are subject to delisting unless the company appeals the determination.

AI Assistant

BONE BIOLOGICS CORP

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.